Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $73.26 +0.48%
EPS Growth %: +19.1%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +19.1%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Boston Scientific sees FY2018 EPS of $1.38-$1.40, versus the consensus of $1.40. Boston Scientific sees FY2018 revenue of $9.787-9.827 billion, versus the consensus of $9.85 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $85 at Mizuho
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Federated Hermes (FHI) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
